Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.

CONCLUSIONS: Rapid development of a live-attenuated RSV vaccine could contribute substantially to reducing the global burden of RSV disease. PMID: 32871092 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - Category: Respiratory Medicine Authors: Tags: Am J Respir Crit Care Med Source Type: research